Alx Oncology Holdings ALXO
NASDAQ ALXO
$2.01 -0.02 (-0.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alx Oncology Holdings (ALXO) Amortizatization of Intangibles (2022 - 2026)

Alx Oncology Holdings (ALXO) posted Amortizatization of Intangibles of $199000.0 for Q1 2026, up 6.99% sequentially from $186000.0 in Q4 2025, and down 62.17% YoY from $526000.0 in Q1 2025.

Analysis

Alx Oncology Holdings (ALXO) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Alx Oncology Holdings has reported Amortizatization of Intangibles for 5 years, with the latest figure at $199000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 62.17% year-over-year to $199000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $915000.0 (down 74.79% YoY) and the FY2025 annual result came in at $1.2 million, down 73.33% from the prior year.
  • Amortizatization of Intangibles advanced to $199000.0 in Q1 2026 per ALXO's latest filing, from $186000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $1.9 million in Q4 2023 and troughed at -$107000.0 in Q1 2022.
  • A 5-year average of $795588.2 and a median of $684000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles soared 41150.0% in 2023, then plunged 79.14% in 2025.
  • Over 5 years, Amortizatization of Intangibles stood at $684000.0 in 2022, then soared by 175.0% to $1.9 million in 2023, then slumped by 60.82% to $737000.0 in 2024, then tumbled by 74.76% to $186000.0 in 2025, then gained by 6.99% to $199000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $199000.0, $186000.0, and $219000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Alx Oncology Holdings 272.64 Mn 272.64 Mn - 341,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 341,000.00
Mar 31, 2026 199,000.00
Dec 31, 2025 186,000.00
Sep 30, 2025 219,000.00
Jun 30, 2025 311,000.00
Mar 31, 2025 526,000.00
Dec 31, 2024 737,000.00
Sep 30, 2024 1.05 Mn
Jun 30, 2024 1.32 Mn
Mar 31, 2024 1.55 Mn
Dec 31, 2023 1.88 Mn
Sep 30, 2023 1.84 Mn
Jun 30, 2023 1.65 Mn
Mar 31, 2023 1.11 Mn
Dec 31, 2022 684,000.00
Sep 30, 2022 359,000.00
Jun 30, 2022 4,000.00
Mar 31, 2022 -107,000.00